Establishing a Registry for Post-COVID-19 Vaccination Syndromes and Comprehensive Analysis of COVID-19 Vaccine-Related Outcomes

Establishing a Registry for Post-COVID-19 Vaccination Syndromes and Comprehensive Analysis of COVID-19 Vaccine-Related Outcomes - Establishing a Registry for Post-COVID-19 Vaccination Syndromes and Comprehensive Analysis of COVID-19 Vaccine-Related Outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053578

Enrollment

300

Registered

2024-02-09

Start date

2023-12-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-COVID-19 vaccination syndromes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients providing written consent for registry inclusion will be incorporated into the study. - Patients who visited or were admitted to a research institution between December 2020 and August 31, 2023, and exhibited symptoms deemed by researchers as definitively or likely related to the vaccine.

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
The primary endpoint of the study is the characterization of adverse events that are definitely or almost certainly related to the novel coronavirus vaccine.	—

Secondary

Measure	Time frame
- Occurrence or non-occurrence of Grade3 or above adverse events - Presence or absence of adverse events(adverse reactions) for which acausal relationship could not be ruled out - Time to onset of adverse events, Grade3 or above adverse events and adverse reactions	—

Countries

Japan

Contacts

Public ContactShinichiro Kodama

Japanese Society for Vaccine-related Complications Not applicable

info@jsvrc.jp0797-86-1313

Outcome results